HAE
Haemonetics Corporation
HAE's fundamentals are mixed, but it looks expensive: trading at 54x earnings, above its usual 42x.
HAE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Under pressure |
HAE's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is under pressure.
HAE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $56.99 | -54% |
| Fair | 41x | $93.28 | -24% |
| Current | 54x | $123 | — |
| Expensive | 66x | $150 | +22% |
Historical ranges are pointers, not guarantees.
HAE's PE is in its expensive range at 54x.
HAE Forward outlook
There aren't enough analyst estimates for HAE to show an outlook.
HAE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.26 | -34% |
| Q2 2026 | $2.07 | -37% |
| Q1 2026 | $2.05 | -38% |
| Q4 2025 | $3.63 | +43% |
| Q3 2025 | $3.42 | +42% |
| Q2 2025 | $3.27 | +47% |
| Q1 2025 | $3.31 | +45% |
| Q4 2024 | $2.54 | +2.8% |
HAE earned $2.26 per share over the past year, down 34% from the year before.
HAE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $357.8M | +9.3% |
| Q2 2026 | $339.4M | +5.6% |
| Q1 2026 | $346.4M | +4.8% |
| Q4 2025 | $339M | -2.7% |
| Q3 2025 | $327.3M | -5.3% |
| Q2 2025 | $321.4M | -4.4% |
| Q1 2025 | $330.6M | -3.7% |
| Q4 2024 | $348.5M | +3.7% |
HAE's revenue has picked up after two years of holding roughly level: $358M last quarter, up 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +3.1 points |
| Q2 2026 | 17% | +0.2 points |
| Q1 2026 | -6.7% | -28 points |
| Q4 2025 | 20% | +2.9 points |
| Q3 2025 | 18% | +2.9 points |
| Q2 2025 | 17% | +4.9 points |
| Q1 2025 | 22% | +13 points |
| Q4 2024 | 17% | +3.3 points |
HAE's operating margin was 21% last quarter, up 3.1 points from the same quarter a year ago.
HAE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $113.3M | +6.6% |
| Q2 2026 | $44.4M | +226% |
| Q1 2026 | $53.3M | -47% |
| Q4 2025 | $87.2M | +148% |
| Q3 2025 | $106.3M | +170% |
| Q2 2025 | $13.6M | +$46.7M |
| Q1 2025 | $100.9M | +86% |
| Q4 2024 | $35.2M | +$58.1M |
HAE generated $298M in free cash flow over the past year, up 16% from the year before.
HAE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +759K shares |
| 1 year | -2.5% | -1.2M shares |
| 3 years | -9.6% | -4.9M shares |
| 5 years | -9.7% | -5M shares |
| Available history | -10% | -5.2M shares |
HAE has 46M diluted shares, down 2.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | $100M |
| Q4 2025 | — |
| Q1 2025 | $150M |
| Q4 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
HAE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 2.4x | Moderate |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 3.1x | Elevated |
HAE's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
HAE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.5 | Overbought |
| Stochastic | 82.3 | Overbought |
HAE's weekly RSI is 79 (overbought) and its Stochastic is 82 (overbought).
HAE PE vs Healthcare Sector
| Metric | HAE | Sector median | Relative |
|---|---|---|---|
| PE | 54x | 26x | 110% above |
| PE % | 67 | 29 | 38 pts above |
HAE is trading at 54x earnings, a 110% premium to the Healthcare sector's median of 26x.
HAE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.0 | 5.8% above |
| 20 week MA | $101.3 | 21% above |
| 50 week MA | $80.9 | 52% above |
| 100 week MA | $72.9 | 68% above |
| 200 week MA | $78.4 | 57% above |
HAE has climbed back above all five of its weekly moving averages, and it's now 57% above its 200-week average.
HAE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $115.9 | $118.8 | +2.4% |
| 2021 | $118.8 | $54.2 | -54% |
| 2022 | $54.2 | $79.2 | +46% |
| 2023 | $79.2 | $85.5 | +8% |
| 2024 | $85.5 | $77.6 | -9.3% |
| 2025 | $77.6 | $80.3 | +3.5% |
| 2026 YTD | $80.3 | $122.7 | +53% |
HAE has finished higher in four of the last six years. It's up 53% so far in 2026.